Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

BLT ?3.3mm NC, SLA? 8mm, Ti, Loxim: medical device reports filed with FDA

2,609 reports name it, 2019–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

2,609
device reports naming the brand
0% of all MAUDE reports · about 377 a year
718
reports, 12 months to August 2026
655 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 2,609 reports that name the brand "BLT ?3.3mm NC, SLA? 8mm, Ti, Loxim" (endosseous dental implant), received between August 2019 and August 2026; the manufacturer given most often on reports is Institut Straumann. Spellings of one product vary from report to report.

718 reports arrived in the 12 months to August 2026, up 10% from 655 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (83.9%), loss of osseointegration (14.1%) and fracture (0.5%). The patient problems coded most often are fibrosis, pain and inflammation. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

091182Sep 2021: 12Oct 2021: 17Nov 2021: 14Dec 2021: 142022Jan 2022: 12Feb 2022: 15Mar 2022: 17Apr 2022: 38May 2022: 19Jun 2022: 24Jul 2022: 21Aug 2022: 21Sep 2022: 12Oct 2022: 26Nov 2022: 29Dec 2022: 212023Jan 2023: 20Feb 2023: 13Mar 2023: 26Apr 2023: 21May 2023: 32Jun 2023: 32Jul 2023: 32Aug 2023: 32Sep 2023: 30Oct 2023: 31Nov 2023: 34Dec 2023: 442024Jan 2024: 35Feb 2024: 40Mar 2024: 43Apr 2024: 45May 2024: 47Jun 2024: 59Jul 2024: 48Aug 2024: 49Sep 2024: 55Oct 2024: 24Nov 2024: 50Dec 2024: 582025Jan 2025: 49Feb 2025: 45Mar 2025: 22Apr 2025: 29May 2025: 0Jun 2025: 182Jul 2025: 56Aug 2025: 85Sep 2025: 84Oct 2025: 54Nov 2025: 70Dec 2025: 842026Jan 2026: 61Feb 2026: 48Mar 2026: 52Apr 2026: 59May 2026: 39Jun 2026: 67Jul 2026: 48Aug 2026: 52

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

03807602019: 4220192020: 6320202021: 16320212022: 25520222023: 34720232024: 55320242025: 76020252026: 4262026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%2,609
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report96.9%2,529
Voluntary report0%0
User facility report0%0
Distributor report3.1%80
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate2,19083.9%62.8%
Loss of osseointegration36714.1%22.4%
Fracturea broken bone120.5%1.6%
Difficult to insertthe device was hard to insert100.4%0.4%
Insufficient device problem information10%0.2%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis55621.3%
Painpain, site not specified30911.8%
Inflammationinflammation1315%
Swelling/ edema863.3%
Hemorrhage/blood loss/bleeding632.4%
Tissue damage552.1%
Fistula291.1%
Abscessa collection of pus200.8%
Numbnessnumbness120.5%
Hyperresponsive to stimuli90.3%
Hypersensitivity/allergic reaction70.3%
Inadequate osseointegration40.2%
Swellingswelling40.2%
Failure of implant30.1%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureBLT ?3.3mm NC, SLA? 8mm, Ti, LoximProduct code DZEAll MAUDE reports
Reports2,6093,924,24126,136,888
Share of that pool—0.1%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer96.9%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about BLT ?3.3mm NC, SLA? 8mm, Ti, Loxim reports

How many FDA reports name BLT ?3.3mm NC, SLA? 8mm, Ti, Loxim?

2,609 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 718 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (83.9%), loss of osseointegration (14.1%), fracture (0.5%), difficult to insert (0.4%) and insufficient device problem information (0%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (96.9%) and distributor reports (3.1%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that BLT ?3.3mm NC, SLA? 8mm, Ti, Loxim was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.